Related Experiment Video
Updated: Jun 22, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Advances in Ketogenic Diet Therapies in Pediatric Epilepsy: A Systematic Review
Dilshad Parveen1, Vidisha Jain2, Dhivya Kannan3
1Ganesh Shankar Vidyarthi Memorial Medical College, Kanpur, India.
Insights
The ketogenic diet effectively reduces seizure frequency and severity in children and adolescents with epilepsy. While side effects are manageable, its success depends on patient adherence and existing health conditions.
Area of Science:
- Neurology
- Pediatric Medicine
- Nutritional Science
Background:
- Epilepsy is a neurological disorder affecting children and adolescents, often requiring diverse treatment strategies.
- The ketogenic diet, a high-fat, low-carbohydrate regimen, has emerged as a potential therapeutic option for drug-resistant epilepsy.
Approach:
- A systematic literature search was performed using PubMed, adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
- Included studies focused on children and adolescents with epilepsy, analyzing various ketogenic diet formulations and their impact on seizure control.
- Twelve studies meeting specific inclusion criteria were selected for data extraction on study design, duration, sample size, population, and intervention type.
Key Points:
- The ketogenic diet and its modified versions demonstrated significant benefits in reducing seizure frequency and severity in pediatric epilepsy patients.
- Commonly observed adverse effects included gastrointestinal disturbances, dehydration, dyslipidemia, hyperuricemia, infection, and metabolic acidosis, which were generally manageable.
- Variations of the ketogenic diet proved effective as both adjunctive and alternative treatments for epilepsy in this population.
Conclusions:
- The ketogenic diet is a viable treatment option for managing epilepsy in children and adolescents, offering seizure reduction benefits.
- Treatment success and tolerability are influenced by individual patient compliance and the presence of comorbidities.
- Further research may explore optimizing ketogenic diet protocols to maximize efficacy and minimize adverse events in pediatric epilepsy.
Abstract:
Objective: To review the effects of the ketogenic diet on epilepsy in children and adolescents.
Abstract:
Data Sources: A literature search was conducted in PubMed with no publication date or language restrictions based on the Preferred Reporting Items for Systematic Reviews and Meta Analyses guidelines. Keywords used included children, adolescent, ketogenic diet, epilepsy, and seizure.
Abstract:
Study Selection: After excluding articles that did not meet the inclusion criteria, such as missing variables of study, adult population, and nonrandomized clinical trials, a total of 12 studies were included in the final review.
Abstract:
Data Extraction: Data on study design, duration, sample size, population, and type of intervention were collected using a standard template.
Abstract:
Results: The ketogenic diet and its modified versions were noted to have beneficial effects in reduction of seizure frequency and severity, with manageable adverse effects such as gastrointestinal disturbances, dehydration, dyslipidemia, hyperuricemia, infection, and metabolic acidosis.
Abstract:
Conclusions: Depending on patient compliance and comorbidities, all variations of the ketogenic diet were found to be helpful for seizure treatment, whether as an additive or an alternative treatment option, for children and adolescents with epilepsy.
Abstract:
Prim Care Companion CNS Disord 2024;26(3):23r03661.
Abstract:
Author affiliations are listed at the end of this article.
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Electroconvulsive Therapy

